全文获取类型
收费全文 | 1357篇 |
免费 | 79篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 163篇 |
妇产科学 | 31篇 |
基础医学 | 176篇 |
口腔科学 | 26篇 |
临床医学 | 134篇 |
内科学 | 321篇 |
皮肤病学 | 22篇 |
神经病学 | 55篇 |
特种医学 | 22篇 |
外科学 | 126篇 |
综合类 | 27篇 |
预防医学 | 85篇 |
眼科学 | 70篇 |
药学 | 106篇 |
中国医学 | 6篇 |
肿瘤学 | 53篇 |
出版年
2023年 | 15篇 |
2022年 | 38篇 |
2021年 | 62篇 |
2020年 | 36篇 |
2019年 | 44篇 |
2018年 | 49篇 |
2017年 | 34篇 |
2016年 | 49篇 |
2015年 | 43篇 |
2014年 | 69篇 |
2013年 | 82篇 |
2012年 | 102篇 |
2011年 | 108篇 |
2010年 | 40篇 |
2009年 | 42篇 |
2008年 | 104篇 |
2007年 | 89篇 |
2006年 | 64篇 |
2005年 | 55篇 |
2004年 | 39篇 |
2003年 | 41篇 |
2002年 | 19篇 |
2001年 | 21篇 |
2000年 | 9篇 |
1999年 | 23篇 |
1998年 | 12篇 |
1997年 | 10篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 5篇 |
1992年 | 13篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 6篇 |
1987年 | 8篇 |
1985年 | 8篇 |
1984年 | 3篇 |
1983年 | 8篇 |
1982年 | 10篇 |
1981年 | 5篇 |
1979年 | 3篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1973年 | 4篇 |
1972年 | 7篇 |
1971年 | 5篇 |
1970年 | 3篇 |
1969年 | 2篇 |
1968年 | 3篇 |
排序方式: 共有1438条查询结果,搜索用时 46 毫秒
41.
Prashant Pandey Divya Setya Vijay Sinha Anil Bhatt Amit Devra Amit Pande Praveen Kumar Shweta Ranjan 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2020,24(5):578-590
Successful renal transplantation across HLA barrier in sensitized individuals has been on the rise during the past decade, primarily due to improved desensitization regimes. The aim of this study was to share outcome of desensitization in renal transplant recipients with donor‐specific anti‐HLA antibodies (DSA). This was a retrospective analysis of all HLA immunized individuals who were prospective renal transplant recipients. All such patients underwent preconditioning as per the institutional desensitization protocol. Complement‐dependent cytoxicity‐based crossmatch (CDC‐XM), luminex‐based crossmatch (LM‐XM) and flowcytometry‐based crossmatch (FC‐XM) were done in all cases. If any of these tests turned out positive, single antigen bead assay (SAB) was performed. Desensitization for DSA was performed in 55 patients and all patients were followed‐up for 1 year to assess graft function and patient outcome. CDC‐XM being a less sensitive assay, could not detect incompatibility in 29 (52.73%) cases. After desensitization, even though SAB and LM‐XM results revealed an MFI within acceptable range, FC‐XM being an extremely sensitive assay, continued to give a positive result in eight (14.55%) cases. The mean ± SD number of pretransplant TPE were 3.44 ± 0.98 (2‐11). Out of 55, there were 10 patients who were lost to follow up. Patient and graft survival of 45 patients at 1 year was found to be 100%. Preconditioning for renal transplants in the form of immunosuppression with TPE is an extremely useful auxiliary for transplantation in HLA sensitized renal transplant recipients. 相似文献
42.
Shweta Naik Jyoti Sharma Rameshwor Yengkom Vijay Kalrao Atul Mulay 《Indian Journal of Critical Care Medicine》2014,18(3):129-133
Background:
Acute kidney injury (AKI) is common in patients in the pediatric intensive care unit (PICU) and is associated with poor outcome. We conducted the present study to determine the incidence, risk factors and outcomes of AKI in the PICU.Materials and Methods:
We collected data retrospectively from case records of children admitted to the PICU during one year. We defined and classified AKI according to modified pRIFLE criteria. We used multivariate logistic regression to determine risk factors of AKI and association of AKI with mortality and morbidity.Results:
Of the 252 children included in the study, 103 (40.9%) children developed AKI. Of these 103 patients with AKI, 39 (37.9%) patients reached pRIFLE max of Risk, 37 (35.9%) patients reached Injury, and 27 (26.2%) had Failure. Mean Pediatric Risk of Mortality (PRISM III) score at admission was higher in patients with AKI than in controls (P < 0.001). 相似文献43.
Aileen K. Wang Shweta Sharma Paul Kim Karen Mrejen-Shakin 《Indian Journal of Critical Care Medicine》2014,18(7):456-460
We report a case of symptomatic hypomagnesaemia in medical intensive care unit that is strongly related to proton pump inhibitors (PPIs) and provide literature review. A 65-year-old male with severe gastroesophageal reflux on omeprazole 20 mg orally twice a day, who presented to the hospital with abdominal pain, nausea, diarrhea, and new onset seizures. On admission, his serum magnesium level was undetectable. Electrocardiogram showed a new right bundle branch block with a prolonged QT interval. The hypomagnesemia was corrected with aggressive magnesium supplementation and hypomagnesemia resolved only after the PPI was stopped. Neurologic and cardiac abnormalities were corrected. This is a life-threatening case of an undetectable magnesium level strongly associated with PPI use. In critically, ill patients with refractory hypomagnesemia, we advocate considering changing gastrointestinal prophylaxis from a PPI to a histamine-receptor blocker. 相似文献
44.
45.
Shweta Urva PhD Tamer Coskun MD Corina Loghin MD Xuewei Cui PhD Emily Beebe BS Libbey O'Farrell BS Daniel A. Briere MS Charles Benson MD Michael A. Nauck MD Axel Haupt MD 《Diabetes, obesity & metabolism》2020,22(10):1886-1891
The effect of dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) tirzepatide on gastric emptying (GE) was compared to that of GLP-1RAs in non-clinical and clinical studies. GE was assessed following acute and chronic treatment with tirzepatide in diet-induced obese mice versus semaglutide or long-acting GIP analogue alone. Participants [with and without type 2 diabetes (T2DM)] from a phase 1, 4-week multiple dose study received tirzepatide, dulaglutide or placebo. GE was assessed by acetaminophen absorption. In mice, tirzepatide delayed GE to a similar degree to that achieved with semaglutide; however, these acute inhibitory effects were abolished after 2 weeks of treatment. GIP analogue alone had no effect on GE or on GLP-1's effect on GE. In participants with and without T2DM, once-weekly tirzepatide (≥5 and ≥4.5 mg, respectively) delayed GE after a single dose. This effect diminished after multiple doses of tirzepatide or dulaglutide in healthy participants. In participants with T2DM treated with an escalation schedule of tirzepatide 5/5/10/10 or 5/5/10/15 mg, a residual GE delay was still observed after multiple doses. These data suggest that tirzepatide's activity on GE is comparable to that of selective GLP-1RAs. 相似文献
46.
47.
48.
49.
Acute promyelocytic leukemia (APL) has evolved from being a deadly to a highly curable disease, due to targeted molecular therapy with all-trans retinoic acid (ATRA). As a result, the incidence of early hemorrhagic deaths for which APL is notorious has reduced to 5-10% as reported in clinical trials. These results are not replicated outside of clinical trials as is evident from recent population-based registries. High incidence of early hemorrhagic deaths remains the greatest contributor to treatment failure in this otherwise curable leukemia. Additionally, thrombosis is now being increasingly recognized in APL patients and may be associated with ATRA usage. 相似文献
50.